QHSLab, Inc. Furnishes January 2025 Corporate Presentation in Recent 8-K Filing

QHSLab, Inc. (OTCMKTS:USAQ) recently disclosed its January 2025 Corporate Presentation in a Current Report on Form 8-K filed with the Securities and Exchange Commission (SEC) on January 21, 2025. The Company, in accordance with Regulation FD, provided insights into its business and operations through the released Presentation on that date.

The Corporate Presentation, as per Exhibit 99.1 attached to the filing, highlights key details regarding QHSLab, Inc.’s activities and strategic direction. It is imperative to note that the information presented in this Current Report on Form 8-K, inclusive of the exhibit, is being furnished under Item 7.01 and is not to be considered as ‘filed’ for the Securities Exchange Act of 1934, or subject to its liabilities.

QHSLab, Inc. emphasizes that by submitting this Current Report on Form 8-K and sharing the enclosed information, they do not affirm the materiality of the disclosed data as required solely by Regulation FD. Furthermore, the Company explicitly disclaims any obligation to publicize updates or modifications to its expectations, forward-looking statements, or shifts in circumstances.

In conclusion, QHSLab, Inc. stresses its commitment to transparent communication with stakeholders. They utilize various channels like their official website (https://usaqcorp.com), press releases, and social media platforms such as Twitter, LinkedIn, Facebook, and Instagram, to disseminate information to investors, the media, and the public interested in the Company. It is advised that individuals review the Company’s financial and business information shared through these channels, as some content may be deemed as material information in compliance with regulatory standards.

Alongside the Corporate Presentation, the 8-K filing also includes details of additional means employed by QHSLab, Inc. to foster public disclosure. The Company encourages investors and interested parties to stay updated on corporate developments through their website and designated social media profiles.

Investors and market participants should refer to the complete 8-K filing on the SEC’s official website for comprehensive details of the Corporate Presentation and additional disclosures made by QHSLab, Inc.

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read QHSLab’s 8K filing here.

About QHSLab

QHSLab, Inc, a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine.